Hutch News
Results per Page:
Hit the “reset” button on acquired drug resistance of cancer cells
From the Bradley Lab, Public Health Sciences and Basic Sciences Divisions and collaborating Abdel-Wahab Lab, Memorial Sloan Kettering Cancer Center
Models of pediatric acute megakaryoblastic leukemia lead to new potential therapies
From the Meshinchi Lab, Clinical Research Division
Blood and Marrow Transplant Reunion returns to Fred Hutch
Hundreds gather in Seattle to celebrate life, science and cancer survivorship
Subverting the immunoproteasome in acute myeloid leukemia
From the Chapuis and Greenberg Labs, Clinical Research Division
Engaging cancer cells in a high stakes game of spot the imposter
From the Bradley Lab, Public Health Sciences and Basic Sciences Divisions
Testing cord blood transplants as a cure for leukemia — and HIV
New clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia
Novel transplant approach improves the odds for leukemia patients
Naïve T cells that lead to graft-vs.-host disease removed with magnets
Examining genomic features of infant acute myeloid leukemia
From the Meshinchi Lab, Clinical Research Division
Toward better cures for kids with AML: Q&A with Dr. Soheil Meshinchi
How researchers are developing personalized therapies for the deadliest childhood leukemia that have fewer side effects
Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal
T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers
Unique set of tissue samples ‘ready to teach’ lessons about pediatric leukemia
Hutch-based repository leads to lifesaving treatments for young cancer patient
Bringing a leukemia treatment back to life with precision medicine
New research writes latest chapter in one drug's story
Remembering leukemia researcher Dr. Steve Collins
Among 'a lot of brilliant guys,' the leukemia clinician-researcher stood out for his science — and much more
Good News: Dr. Glenda Gray among Time magazine’s ‘100 most influential’
Celebrating faculty and staff achievements
A Q&A with immunotherapy researcher Dr. Rachel Perret
As part of a world-class immunotherapy research team, Perret is working her ‘dream job’ — trying to bring T-cell therapy to all who need it
Immunotherapy shows promise in preventing leukemia relapse
Group of 12 high-risk patients who received engineered T cells after bone marrow transplant still in remission
Umbilical cord blood transplant linked to lower relapse in high-risk leukemia patients
Study compares ‘alternative’ donor source vs. traditional transplantation of blood stem cells from an adult, unrelated donor